Quantcast

Latest MedImmune Stories

2011-07-18 11:00:00

GAITHERSBURG, Md., July 18, 2011 /PRNewswire/ -- MedImmune announced today that it has begun shipping FluMist® (Influenza Vaccine Live, Intranasal) to influenza vaccine distributors who service health care providers throughout the United States. MedImmune expects to provide approximately 15 -16 million doses of its trivalent (three-strain) nasal spray flu vaccine for the 2011-2012 influenza season through a variety of private health care practices, public health...

2011-07-18 05:00:00

GAITHERSBURG, Md., July 18, 2011 /PRNewswire/ -- MedImmune has received confirmation from the U.S. Food & Drug Administration (FDA) that the Agency has filed the Company's supplemental Biologics License Application (sBLA) for a quadrivalent (four-strain) version of FluMist® (Influenza Vaccine Live, Intranasal). The company submitted the sBLA early in the second quarter of this year. Currently licensed seasonal influenza vaccines are trivalent, containing three strains...

2011-07-15 07:20:16

(Ivanhoe Newswire)--Swine flu may be able to be detected through a simple breath test. Researchers have been investigating an easy and non-invasive breath test that measures biomolecules that accumulate in response to the strain caused by H1N1 flu virus. This test could mean a future without vaccination shortages. Those diagnosed with swine flu typically have a fever or high temperature and may also experience aching muscles, sore throat, or a dry cough. The symptoms are very similar to types...

2011-06-30 06:00:00

- Phase II part B confirms results obtained in Phase II part A - - Company's results continue to be amongst the best for influenza vaccine manufacturing technologies - QUEBEC CITY, June 30, 2011 /PRNewswire/ - Medicago Inc. (TSX: MDG) a biotechnology company focused on developing highly effective and competitive vaccines based on proprietary manufacturing technologies and Virus-Like Particles (VLPs), today reported positive final results from a Phase II human clinical trial with...

2011-06-23 00:00:00

BANGALORE, India, June 23, 2011 /PRNewswire/ -- Jubilant Biosys Ltd., Bengaluru, based subsidiary of Jubilant Life Sciences Ltd., and AstraZeneca, today announced another successful delivery of an early stage milestone in the Pain therapeutic area. The collaboration, initiated two years ago in the Neuroscience therapeutic area, has now expanded to Cardiovascular and Metabolic diseases and focuses on the delivery of a steady stream of preclinical outcomes to AstraZeneca,...

2011-06-16 02:26:00

NESS ZIONA, Israel, June 16, 2011 /PRNewswire/ -- BiondVax Pharmaceuticals Ltd. (TASE: BNDX) [http://www.biondvax.com ] today announced positive results from its first Phase II clinical trial of the Multimeric-001 Universal Influenza Vaccine. The vaccine was found to be safe and well tolerated, and induced robust immune responses, successfully meeting both the primary safety and immunogenicity endpoints, as well as additional secondary immunogenicity endpoints. It was also...

2011-06-08 06:00:00

- All tested doses were found safe and well-tolerated - - A single dose of 5 µg met the 3 CHMP immunogenicity criteria - QUEBEC CITY, June 8, 2011 /PRNewswire/ - Medicago Inc. (TSX: MDG), a biotechnology company focused on developing highly effective and competitive vaccines based on proprietary manufacturing technologies and Virus-Like Particles (VLPs), today reported positive results from a U.S. Phase I human clinical trial with its seasonal influenza vaccine...

2011-06-06 12:40:00

124 current and former female employees will share in settlement involving equal pay PHILADELPHIA, June 6, 2011 /PRNewswire-USNewswire/ -- AstraZeneca, one of the largest pharmaceutical companies in the world, will pay $250,000 to 124 women who were subjected to pay discrimination while working at the corporation's Philadelphia Business Center in Wayne, Pa. The action resolves a lawsuit filed by the U.S. Department of Labor in May 2010 alleging that the company discriminated against...

2011-06-06 11:24:00

STAMFORD, Conn., June 6, 2011 /PRNewswire-USNewswire/ -- AmeriCares has awarded its annual Power of Partnership Award to AstraZeneca for its outstanding commitment to increasing access to health care for people in need both here at home and throughout the developing world. In the past year alone, the pharmaceutical company renewed its support for the only breast cancer treatment program for Cambodia's poor, assembled over 14,000 hygiene kits for disaster survivors and, for the second year...

2011-05-31 02:00:00

ALDERLEY PARK and WELWYN GARDEN CITY, England, May 31, 2011 /PRNewswire/ -- AstraZeneca (NYSE: AZN) and Heptares Therapeutics today announced they have entered a four-year collaboration focused on the potential discovery and development of new medicines targeting G-protein coupled receptors (GPCRs). GPCRs are among the largest and most important family of proteins found in the human body, yet they become highly unstable when removed from their natural membrane-bound environments. This...


Word of the Day
barratry
  • The offense of persistently instigating lawsuits, typically groundless ones.
  • An unlawful breach of duty on the part of a ship's master or crew resulting in injury to the ship's owner.
  • Sale or purchase of positions in church or state.
This word ultimately comes from the Old French word 'barater,' to cheat.
Related